Skip to main content

Advertisement

SpringerLink
Log in

Management of Type 1 Diabetes in Children and Adolescents

  • Symposium on Pediatric Endocrinology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Type 1 diabetes (T1D) is estimated to have a prevalence of approximately 1 in 5000 among Indian children. Living with T1D is a challenge for the child and the family because of the significant burden of treatment in terms of regular injections and monitoring of blood sugar, and risk of acute and long term complications that this condition imposes. Optimal glycemic control in T1D requires a meticulous balance of insulin therapy with diet and exercise. With the earlier insulin regimens this required lot of discipline in the eating and activity pattern, which led to significant curtailment of the lifestyle. Now, with availability of better insulins, delivery and monitoring devices, greater flexibility in lifestyle has become possible. The ultimate breakthrough in terms of therapy of T1D shall be easy availability of accurate and affordable closed loop systems, and ‘cure’ through islet or stem cell transplant. A review of the ambulatory management of T1D in children and adolescents and the upcoming therapeutic advances is being presented in this paper.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Raha O, Chowdhury S, Dasgupta S, Raychaudhuri P, Sarkar BN, Raju PV, et al. Approaches in type 1 diabetes research: A status report. Int J Diabetes Dev Ctries. 2009;29:85–101.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Kalra S, Kalra B, Sharma A. Prevalence of type 1 diabetes mellitus in Karnal district, Haryana state, India. Diabetol Metab Syndr. 2010;2:14.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Gan MJ, Albanese-O'Neill A, Haller MJ. Type 1 diabetes: Current concepts in epidemiology, pathophysiology, clinical care, and research. Curr Probl Pediatr Adolesc Health Care. 2012;42:269–91.

    Article  PubMed  Google Scholar 

  4. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  5. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.

    Google Scholar 

  6. Hypoglycemia in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997;46:271–86.

  7. Mehta SN, Wolfsdorf JI. Contemporary management of patients with type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39:573–93.

    Article  CAS  Google Scholar 

  8. Vajo Z, Fawcett J, Duckworth WC. Recombinant DNA technology in the treatment of diabetes: Insulin analogs. Endocr Rev. 2001;22:706–17.

    Article  CAS  PubMed  Google Scholar 

  9. Galli-Tsinopoulou A, Stergidou D. Insulin analogues for type 1 diabetes in children and adolescents. Drugs Today (Barc). 2012;48:795–809.

    CAS  Google Scholar 

  10. Danne T. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus. Clin Ther. 2007;29:S145–52.

    Article  CAS  PubMed  Google Scholar 

  11. Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab. 2009;11:372–8.

    Article  CAS  PubMed  Google Scholar 

  12. Chase HP, Arslanian S, White NH, Tamborlane WV. Insulin glargine versus intermediate -acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. J Pediatr. 2008;153:547–53.

    Article  CAS  PubMed  Google Scholar 

  13. Seth A, Maheshwari A. Common endocrine problems in children (hypothyroidism and type 1 diabetes mellitus). Indian J Pediatr. 2013; doi:10.1007/s12098-013-1101-0.

  14. Tamborlane WV, Sikes KA. Insulin therapy in children and adolescents. Endocrinol Metab Clin N Am. 2012;41:145–60.

    Article  CAS  Google Scholar 

  15. Bangstad HJ, Danne T, Deeb L, Jarosz-Chobot P, Urakami T, Hanas R. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:82–99.

    Article  PubMed  Google Scholar 

  16. Sherr J, Tamborlane WV. Past, present, and future of insulin pump therapy: Better shot at diabetes control. Mt Sinai J Med. 2008;75:352–61.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kordonouri O, Hartmann R, Danne T. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps. Diabetes Res Clin Pract. 2011;93:S118–24.

    Article  CAS  PubMed  Google Scholar 

  18. Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: Monitoring may be the key. J Pediatr. 2004;144:660–1.

    Article  PubMed  Google Scholar 

  19. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:71–81.

    Article  PubMed  Google Scholar 

  20. Szypowska A, Ramotowska A, Dzygalo K, Golicki D. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: Systematic review and meta-analysis of randomized trials. Eur J Endocrinol. 2012;166:567–74.

    Article  CAS  PubMed  Google Scholar 

  21. Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. Diabet Med. 2006;23:278–84.

    Article  CAS  PubMed  Google Scholar 

  22. Smart C, Aslander-van Vliet E, Waldron S. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:100–17.

    Article  PubMed  Google Scholar 

  23. Wolever TM, Hamad S, Chiasson JL, Josse RG, Leiter LA, Rodger NW, et al. Day-to-day consistency in amount and source of carbohydrate associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr. 1999;18:242–7.

    Article  CAS  PubMed  Google Scholar 

  24. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325:746–52.

    Article  PubMed Central  Google Scholar 

  25. Brink S, Laffel L, Likitmaskul S, Liu L, Maguire AM, Olsen B, et al. Sick day management in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:146–53.

    Article  PubMed  Google Scholar 

  26. Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin N Am. 2000;29:707–23.

    Article  CAS  Google Scholar 

  27. Sivanandan S, Sinha A, Jain V, Lodha R. Management of diabetic ketoacidosis. Indian J Pediatr. 2011;78:576–84.

    Google Scholar 

  28. Workgroup on Hypoglycaemia, ADA. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28:1245–9.

    Article  Google Scholar 

  29. Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2009;10:134–45.

    Article  PubMed  Google Scholar 

  30. Cryer PE. Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45:937–48.

    Article  CAS  PubMed  Google Scholar 

  31. Georgakopoulos K, Katsilambros N, Fragaki M, Poulopoulou Z, Kimbouris J, Sfikakis P, et al. Recovery from insulin-induced hypoglycemia after saccharose or glucose administration. Clin Physiol Biochem. 1990;8:267–72.

    CAS  PubMed  Google Scholar 

  32. Welch IM, Bruce C, Hill SE, Read NW. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: Possible implications for the dietary management of diabetes mellitus. Clin Sci (Lond). 1987;72:209–16.

    CAS  Google Scholar 

  33. Aman J, Wranne L. Hypoglycemia in childhood diabetes. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr Scand. 1988;77:548–53.

    Article  CAS  PubMed  Google Scholar 

  34. Miculis CP, Mascarenhas LP, Boguszewski MC, Campos W. Physical activity in children with type 1 diabetes. J Pediatr (Rio J). 2010;86:271–8.

    Google Scholar 

  35. Pihoker C, Forsander G, Wolfsdorf J, Klingensmith GJ. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2009;10:58–70.

    Article  PubMed  Google Scholar 

  36. Australasian Paediatric Endocrine Group. Clinical practice guidelines: type 1 diabetes in children and adolescents. National Health and Medical Research Council. Available at: http://www.nhmrc.gov.au/publications/synopses/cp102syn.htm Updated March 9, 2005.

  37. American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33:S11–62.

    Article  PubMed Central  Google Scholar 

  38. Jain V, Jain R. Severe limited joint mobility syndrome in a child with type 1 diabetes mellitus. Indian J Pediatr. 2012;79:959–60.

    Article  PubMed  Google Scholar 

  39. Setoodeh A, Mostafavi F, Hedayat T. Glycemic control in Iranian children with type 1 diabetes mellitus: Effect of gender. Indian J Pediatr. 2012;79:896–900.

    Article  PubMed  Google Scholar 

  40. Johnson PR, Jones KE. Pancreatic islet transplantation. Semin Pediatr Surg. 2012;21:272–80.

    Article  PubMed  Google Scholar 

  41. Elleri D, Dunger DB, Hovorka R. Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Med. 2011;9:120.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Authors and Affiliations

  1. Division of Pediatric Endocrinology, Department of Pediatrics, All India Institute for Medical Sciences, New Delhi, 110029, India

    Vandana Jain

Authors
  1. Vandana Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vandana Jain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, V. Management of Type 1 Diabetes in Children and Adolescents. Indian J Pediatr 81, 170–177 (2014). https://doi.org/10.1007/s12098-013-1196-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-013-1196-3

Keywords

Search

Navigation